BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 35684079)

  • 1. Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.
    Kim MB; Bae M; Lee Y; Kang H; Hu S; Pham TX; Park YK; Lee JY
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis.
    Kim B; Farruggia C; Ku CS; Pham TX; Yang Y; Bae M; Wegner CJ; Farrell NJ; Harness E; Park YK; Koo SI; Lee JY
    J Nutr Biochem; 2017 May; 43():27-35. PubMed ID: 28193580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Cholic Acid Exacerbates Liver Fibrosis in NASH Model of Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.
    Ichimura-Shimizu M; Watanabe S; Kashirajima Y; Nagatomo A; Wada H; Tsuneyama K; Omagari K
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugar kelp (Saccharina latissima) inhibits hepatic inflammation and fibrosis in a mouse model of diet-induced nonalcoholic steatohepatitis.
    Kim MB; Lee Y; Bae M; Kang H; Hu S; Pham TX; Lee JY; Park YK
    J Nutr Biochem; 2021 Nov; 97():108799. PubMed ID: 34119629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H; Ahn J; Shin SS; Yoon M
    Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive characterization of metabolic, inflammatory and fibrotic changes in a mouse model of diet-derived nonalcoholic steatohepatitis.
    Kim MB; Lee Y; Bae M; Kang H; Pham TX; Hu S; Lee JY; Park YK
    J Nutr Biochem; 2020 Nov; 85():108463. PubMed ID: 32891893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis.
    Nielsen MH; Gillum MP; Vrang N; Jelsing J; Hansen HH; Feigh M; Oró D
    Am J Physiol Gastrointest Liver Physiol; 2023 May; 324(5):G378-G388. PubMed ID: 36852934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
    Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
    Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Masubuchi S; Ozeki M; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    Exp Anim; 2018 May; 67(2):239-247. PubMed ID: 29311502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cranberry consumption on lipid metabolism and inflammation in human apo A-I transgenic mice fed a high-fat and high-cholesterol diet.
    Caceres C; Kim MB; Bae M; Pham TX; Lee Y; Hu S; O'Neill EN; Kim B; Park YK; Lee JY
    Br J Nutr; 2021 Jul; 126(2):183-190. PubMed ID: 33059793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic metabolic adaptation and adipose tissue expansion are altered in mice with steatohepatitis induced by high-fat high sucrose diet.
    Baiges-Gaya G; Fernández-Arroyo S; Luciano-Mateo F; Cabré N; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; Romeu M; Nogués MR; Camps J; Joven J
    J Nutr Biochem; 2021 Mar; 89():108559. PubMed ID: 33264665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
    Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential metabolic and hepatic transcriptome responses of two miniature pig breeds to high dietary cholesterol.
    Cai Z; Yu C; Fu D; Pan Y; Huang J; Rong Y; Deng L; Chen J; Chen M
    Life Sci; 2020 Jun; 250():117514. PubMed ID: 32145306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Hormone Decreases Hepatic Steatosis, Inflammation, and Fibrosis in a Dietary Mouse Model of Nonalcoholic Steatohepatitis.
    Zhou J; Tripathi M; Ho JP; Widjaja AA; Shekeran SG; Camat MD; James A; Wu Y; Ching J; Kovalik JP; Lim KH; Cook SA; Bay BH; Singh BK; Yen PM
    Thyroid; 2022 Jun; 32(6):725-738. PubMed ID: 35317606
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).
    Han L; Bittner S; Dong D; Cortez Y; Dulay H; Arshad S; Shen WJ; Kraemer FB; Azhar S
    Mol Cell Endocrinol; 2019 Dec; 498():110538. PubMed ID: 31415794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.